Uncategorized
VIDEO: Anti-VEGF, ang-2 combination shows potentially longer duration in wet AMD
FORT LAUDERDALE, Fla. ― At the Retina World Congress, Carl D. Regillo, MD, director of the retina service at Wills Eye Hospital in Philadelphia, discusses results from the STAIRWAY and AVENUE phase 2 studies of faricimab combined with ranibizumab, which showed a potentially longer durability than anti-VEGF alone.